ITIL-306 in Advanced Solid Tumors
Instil Bio
Instil Bio
Instituto do Cancer do Estado de São Paulo
OncoC4, Inc.
AstraZeneca
Rutgers, The State University of New Jersey
M.D. Anderson Cancer Center
Mayo Clinic
Toray Industries, Inc
Numab Therapeutics AG
Medicenna Therapeutics, Inc.
Celldex Therapeutics
M.D. Anderson Cancer Center
Xencor, Inc.
23andMe, Inc.
Hoffmann-La Roche
ADC Therapeutics S.A.
pharmaand GmbH
Sumitomo Pharma America, Inc.
Celldex Therapeutics
pharmaand GmbH
Celldex Therapeutics
Eastern Cooperative Oncology Group
Xencor, Inc.
Xencor, Inc.
Jerome Canady Research Institute for Advanced Biological & Technological Sciences
Abramson Cancer Center at Penn Medicine
Celgene
National Cancer Institute (NCI)
Santa Maria Biotherapeutics
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Alliance for Clinical Trials in Oncology
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Valerio Therapeutics
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)